CN Stock MarketDetailed Quotes

002399 Shenzhen Hepalink Pharmaceutical Group

Watchlist
  • 8.80
  • +0.12+1.38%
Market Closed Jul 12 15:00 CST
12.91BMarket Cap-18565P/E (TTM)

Shenzhen Hepalink Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shenzhen Hepalink Pharmaceutical Group Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

1.37B

+5.55%
EPS(YoY)

0.11

+133.33%
Analyst Rating

Strong Buy

Jul 14, 2024

Shenzhen Hepalink Pharmaceutical Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2020/Q41.790B / ----
--2020/Q3883.279M / ----
--2020/Q21.257B / ----
--2020/Q11.402B / ----
DatePeriodRevenue/EstimateEarnings Call
--2020/Q41.790B / ----
--2020/Q3883.279M / ----
--2020/Q21.257B / ----
--2020/Q11.402B / ----
--------

Unlock Free Earnings Estimates

Shenzhen Hepalink Pharmaceutical Group Earnings Reports

  • Shenzhen Hepalink Pharmaceutical Group: 2024 Interim Performance Forecast

    Jul 12 12:00 ET

  • Shenzhen Hepalink Pharmaceutical Group: 2024 First Quarter Report

    Apr 29 12:00 ET

  • Highpree: Annual Report 2023

    Mar 28 12:00 ET

  • Highpree: 2023 Annual Report Summary

    Mar 28 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 14, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg